EYEG Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 58.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

AB Corporate Bond ETF Insider Trading History Chart

This chart shows the insider buying and selling history at AB Corporate Bond ETF by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AB Corporate Bond ETF Share Price & Price History

Current Price: $34.73
Price Change: Price Increase of +0.1773 (0.51%)
As of 04/17/2024 01:00 AM ET

This chart shows the closing price history over time for EYEG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

AB Corporate Bond ETF Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/29/2021Armistice Capital, LlcDirectorSell400,000$3.00$1,200,000.00View SEC Filing Icon  
7/27/2021Armistice Capital, LlcDirectorSell2,377,695$5.09$12,102,467.55View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for AB Corporate Bond ETF (NASDAQ:EYEG)

64.16% of AB Corporate Bond ETF stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EYEG by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

AB Corporate Bond ETF Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2021Sassicaia Capital Advisers LLC25,000$56K0.2%N/A0.198%Search for SEC Filing on Google Icon
10/22/2021Tuttle Capital Management LLC18,174$41K0.0%N/A0.144%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC90,200$0.33M0.0%-38.5%1.271%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.127,767$0.47M0.0%+193.4%1.800%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC20,177$100K0.0%N/A0.284%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC20,177$100K0.0%N/A0.284%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC3,346,601$16.67M0.4%+84.3%47.149%Search for SEC Filing on Google Icon
5/14/2021Parkman Healthcare Partners LLC75,295$0.38M0.1%N/A1.061%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC146,590$0.73M0.0%N/A2.065%Search for SEC Filing on Google Icon
2/20/2020Geode Capital Management LLC33,686$0.34M0.0%N/A0.832%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
AB Corporate Bond ETF logo
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
Read More on AB Corporate Bond ETF

Today's Range

Now: $34.73
Low: $34.73
High: $34.77

50 Day Range

MA: $1.90
Low: $1.59
High: $2.25

52 Week Range

Now: $34.73
Low: $1.44
High: $8.18

Volume

401 shs

Average Volume

935,975 shs

Market Capitalization

$438.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81